SCHEMBL23488908

SCHEMBL23488908

CC(=O)c1c(C)c2cnc(C)cc2n(C2CCCC2)c1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 18/20 0.61
CCND1 P24385 17/20 0.61
CCND3 P30281 13/20 0.61
CDK6 Q00534 9/20 0.61
CCND2 P30279 6/20 0.51
CDK2 P24941 4/20 0.50
CCNT1 O60563 3/20 0.50
CDK9 P50750 3/20 0.50
CDK1 P06493 1/20 0.50
CCNE1 P24864 1/20 0.50
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
KMT2A Q03164 1/20 0.49
FGFR1 P11362 3/20 0.46
CCNA2 P20248 3/20 0.46
FGFR2 P21802 3/20 0.46
FGFR4 P22455 3/20 0.46
FGFR3 P22607 3/20 0.46
NUAK1 O60285 1/20 0.46
PDGFRB P09619 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21460208 0.88 CDK4 (0.59) CDK4CCND1CCND3CDK6CCND2
SCHEMBL29333468 0.87 CDK4 (0.63) CDK4CCND1CCND3CDK6CCND2
SCHEMBL21482571 0.81 MEN1 (0.55) CDK4CCND1CCND3CDK6CCND2
SCHEMBL31018774 0.80 CDK4 (0.60) CDK4CCND1CCND3CDK6CCND2
SCHEMBL19294159 0.78 CDK4 (0.64) CDK4CCND1CCND3CDK6CCND2
SCHEMBL28404189 0.77 CDK4 (0.63) CDK4CCND1CCND3CDK6CCND2
Pf-06842874 SCHEMBL22553485 0.77 CDK4 (1.00) CDK4CCND1CCND3CDK6
Pf-06842874 SCHEMBL22553637 0.77 CDK4 (1.00) CDK4CCND1CCND3CDK6
Pf-06842874 SCHEMBL22553598 0.77 CDK4 (1.00) CDK4CCND1CCND3CDK6
Pf-06842874 SCHEMBL22553605 0.77 CDK4 (1.00) CDK4CCND1CCND3CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3556758-B1 1,2-DIHYDRO-1,6-NAPHTHYRIDIN-2-ONE DERIVATIVES AS CDK4/6 INHIBITORS CSTONE PHARMACEUTICALS SUZHOU CO LTD (CN) 2024-07-17 EP disclosed
WO-2021110122-A1 COMBINATION THERAPY OF CDK4/6 INHIBITOR 基石药业(苏州)有限公司 2021-06-10 WO disclosed